歡迎您來到深圳欣博盛生物科技有限公司網(wǎng)站!
BioXcell熱銷產(chǎn)品--InVivoPlus anti-mouse CD8α
產(chǎn)品描述:
BioXcell InVivoPlus anti-mouse CD8α克隆號(hào)YTS 169.4單克隆抗體能與小鼠CD8α反應(yīng)。CD8抗原是一種跨膜糖蛋白,作為T細(xì)胞受體的共受體。與TCR一樣,CD8與抗原呈遞細(xì)胞(APC)展示的I類MHC分子結(jié)合。CD8主要在細(xì)胞毒性T細(xì)胞表面表達(dá),但也可在胸腺細(xì)胞、自然殺傷細(xì)胞和一些樹突狀細(xì)胞亞群中發(fā)現(xiàn)。CD8最常見的存在形式是由一個(gè)CD8α和一個(gè)CD8β鏈組成的異二聚體,然而,它也可以是由兩個(gè)CD8α鏈組成的同二聚體。CD8α和CD8β鏈均與免疫球蛋白可變輕鏈具有顯著同源性。每個(gè)CD8鏈的分子量約為34 kDa。BioXcell InVivoPlus anti-mouse CD8α克隆號(hào)YTS 169.4抗體在體內(nèi)使用時(shí)顯示出depleting活性。
 
產(chǎn)品詳情:
產(chǎn)品名稱  | InVivoPlus anti-mouse CD8α  | 
產(chǎn)品貨號(hào)  | BP0117  | 
產(chǎn)品規(guī)格  | 5/25/50/100mg  | 
反應(yīng)種屬  | Mouse  | 
克隆號(hào)  | YTS 169.4  | 
同種型  | Rat IgG2b, κ  | 
免疫原  | CBA mouse thymocytes  | 
實(shí)驗(yàn)應(yīng)用  | in vivo CD8+ T cell depletion  | 
產(chǎn)品形式  | PBS, pH 7.0,Contains no stabilizers or preservatives  | 
純度  | >95%, Determined by SDS-PAGE  | 
聚合  | <5%, Determined by SEC  | 
無菌處理  | 0.2 µm filtration  | 
純化方式  | Protein G  | 
RRID  | AB_10950145  | 
分子量  | 150 kDa  | 
小鼠病原檢測(cè)  | Ectromelia/Mousepox Virus: Negative Hantavirus: Negative K Virus: Negative Lactate Dehydrogenase-Elevating Virus: Negative Lymphocytic Choriomeningitis virus: Negative Mouse Adenovirus: Negative Mouse Cytomegalovirus: Negative Mouse Hepatitis Virus: Negative Mouse Minute Virus: Negative Mouse Norovirus: Negative Mouse Parvovirus: Negative Mouse Rotavirus: Negative Mycoplasma Pulmonis: Negative Pneumonia Virus of Mice: Negative Polyoma Virus: Negative Reovirus Screen: Negative Sendai Virus: Negative Theiler’s Murine Encephalomyelitis: Negative  | 
保存條件  | 抗體原液保存在4°C,不能冷凍保存。  | 
推薦同型對(duì)照  | InVivoPlus rat IgG2b isotype control, anti-keyhole limpet hemocyanin(貨號(hào)BP0090)  | 
推薦抗體稀釋液  | InVivoPure pH 7.0 Dilution Buffer(貨號(hào)IP0070)  | 
為什么選擇InVivoPlus抗體?
InVivoPlus級(jí)別的產(chǎn)品內(nèi)毒素含量更低,經(jīng)過多種實(shí)驗(yàn)驗(yàn)證,更適合用于體內(nèi)實(shí)驗(yàn)研究

該產(chǎn)品自上市已被多篇SCI文獻(xiàn)引用,品質(zhì)有保證,以下是部分已發(fā)表的文獻(xiàn)引用:
應(yīng)用  | 文章  | 
體內(nèi)CD8+T細(xì)胞耗竭 (in vivo CD8+ T cell depletion)  | 1. Vashist, N., et al. (2018). 'Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR Expression' Front Immunol 9: 505. 2. Triplett, T. A., et al. (2018). 'Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme' Nat Biotechnol 36(8): 758-764. 3. Carmi, Y., et al. (2015). 'Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity' Nature 521(7550): 99-104. 4. Burrack, K. S., et al. (2015). 'Myeloid Cell Arg1 Inhibits Control of Arthritogenic Alphavirus Infection by Suppressing Antiviral T Cells' PLoS Pathog 11(10): e1005191. 5. Wensveen, F. M., et al. (2015). 'NK cells link obesity-induced adipose stress to inflammation and insulin resistance' Nat Immunol 16(4): 376-385. 6. Li, Z., et al. (2015). 'Pre-treatment of allogeneic bone marrow recipients with the CXCR4 antagonist AMD3100 transiently enhances hematopoietic chimerism without promoting donor-specific skin allograft tolerance' Transpl Immunol 33(2): 125-129.  | 

更多產(chǎn)品詳情請(qǐng)聯(lián)系 BioXcell 中國授權(quán)代理——欣博盛生物